InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by File Justin J., Chief Financial Officer. Officer active across 2 companies, notably Evofem Biosciences, Inc.. In total, 9 disclosures have been logged. Total volume traded: €68k. The latest transaction was disclosed on 18 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
0450,000 shares0
Common Stock
SEC:0001618835-22-000030:0·
0120,000 shares0
Common Stock
SEC:0001618835-22-000005·
0120,000 shares0
Common Stock
SEC:0001618835-22-000005:0·
€13,35940,594 shares@ €0.32911.55% mcap39.2% of flow
Common Stock
SEC:0001618835-21-000272·
Ideal exit: 16 Sept 2022 (T+270)
€13,35940,594 shares@ €0.32911.55% mcap13.6% of flow
Common Stock
SEC:0001618835-21-000272:0·
Ideal exit: 16 Sept 2022 (T+270)
€20,73124,500 shares@ €0.84622.41% mcap60.8% of flow
Common Stock
SEC:0001618835-21-000148·
Ideal exit: 7 Mar 2022 (T+270)
€20,73124,500 shares@ €0.84622.41% mcap21.2% of flow
Common Stock
SEC:0001618835-21-000148:0·
Ideal exit: 7 Mar 2022 (T+270)
€29,74242,280 shares@ €0.7035100.0% of flow
Common Stock
SEC:0001618835-21-000134·
€29,74242,280 shares@ €0.70353.45% mcap30.4% of flow
Common Stock
SEC:0001618835-21-000134:0·
9 of 9 declarations
About File Justin J.
Justin J. File is the Chief Financial Officer at Evofem Biosciences, Inc. In this role, he is responsible for managing the company's finances, including financial planning and performance analysis. Justin plays a key role in preparing financial reports and managing financial risks.
